Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently alleviates asthma in a mouse model

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wu, Kefei ^a   Ma, Jiexian ^a   Bai, Weiya ^a   Cui, Xiaoxian ^a   Han, Tao ^a   Wang, Shiyuan ^b   Xie, Youhua ^a   Xie, Yanhui ^a  

^a FUDAN UNIVERSITY   (China)

^b Xiamen Amoytop Biotech Co Ltd LTD   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CYTOKINE; DEXAMETHASONE; INTERLEUKIN 2; MACROGOL DERIVATIVE;

ANIMAL; ASTHMA; BAGG ALBINO MOUSE; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; DISEASE MODEL; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; FEMALE; IMMUNOLOGY; METABOLISM; MOUSE; REGULATORY T LYMPHOCYTE; TRACHEA;

ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; BUDESONIDE; CYTOKINES; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION ROUTES; FEMALE; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; POLYETHYLENE GLYCOLS; T-LYMPHOCYTES, REGULATORY; TRACHEA;

EID: 84982239093     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep31562     Document Type: Article

References (46)

1. Gupta, R., Anderson, H. R., Strachan, D. P., Maier, W. & Watson, L. International trends in admissions and drug sales for asthma. Int J Tuberc Lung Dis 10, 138-145 (2006).
2. Holgate, S. T. The epidemic of asthma and allergy. J R Soc Med 97, 103-110 (2004).
3. Robinson, D. S. The role of the T cell in asthma. J Allergy Clin Immunol 126, 1081-1091, 1092-1093 (2010).
4. Vignali, D. A., Collison, L. W. & Workman, C. J. How regulatory T cells work. NAT REV IMMUNOL 8, 523-532 (2008).
5. Stelmaszczyk-Emmel, A., Zawadzka-Krajewska, A., Szypowska, A., Kulus, M. & Demkow, U. Frequency and activation of CD4+ CD25 FoxP3+ regulatory T cells in peripheral blood from children with atopic allergy. Int Arch Allergy Immunol 162, 16-24 (2013).
6. Kearley, J., Barker, J. E., Robinson, D. S. & Lloyd, C. M. Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+ CD25+ regulatory T cells is interleukin 10 dependent. J EXP MED 202, 1539-1547 (2005).
7. Cottrez, F., Hurst, S. D., Coffman, R. L. & Groux, H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J IMMUNOL 165, 4848-4853 (2000).
8. Wilson, M. S. et al. Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells. J IMMUNOL 181, 6942-6954 (2008).
9. Chen, X., Murakami, T., Oppenheim, J. J. & Howard, O. M. Differential response of murine CD4+ CD25+ and CD4+ CD25- T cells to dexamethasone-induced cell death. EUR J IMMUNOL 34, 859-869 (2004).
10. Chen, X., Oppenheim, J. J., Winkler-Pickett, R. T., Ortaldo, J. R. & Howard, O. M. Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+ )CD4(+ )CD25(+ ) T regulatory cells in vivo and enhances their capacity to suppress EAE. EUR J IMMUNOL 36, 2139-2149 (2006).
11. Ma, J. et al. Alleviating allergic airway diseases by means of short-term administration of IL-2 and dexamethasone. J Allergy Clin Immunol 127, 1447-1456 (2011).
12. Thornton, E. E. et al. Spatiotemporally separated antigen uptake by alveolar dendritic cells and airway presentation to T cells in the lung. J EXP MED 209, 1183-1199 (2012).
13. Fontenot, J. D., Gavin, M. A. & Rudensky, A. Y. Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. NAT IMMUNOL 4, 330-336 (2003).
14. Fishburn, C. S. The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics. J Pharm Sci 97, 4167-4183 (2008).
15. Ma, J. et al. Glucocorticoid-induced apoptosis requires FOXO3A activity. Biochem Biophys Res Commun 377, 894-898 (2008).
16. Cote-Sierra, J. et al. Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci USA 101, 3880-3885 (2004).
17. Hall, G., Houghton, C. G., Rahbek, J. U., Lamb, J. R. & Jarman, E. R. Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production. VACCINE 21, 549-561 (2003).
18. Francis, J. N., Till, S. J. & Durham, S. R. Induction of IL-10+ CD4+ CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 111, 1255-1261 (2003).
19. Pereira-Santos, M. C. et al. Expansion of circulating Foxp3+D25bright CD4+ T cells during specific venom immunotherapy. CLIN EXP ALLERGY 38, 291-297 (2008).
20. Sakaguchi, S. & Powrie, F. Emerging challenges in regulatory T cell function and biology. SCIENCE 317, 627-629 (2007).
21. Polte, T. et al. CD137-mediated immunotherapy for allergic asthma. J CLIN INVEST 116, 1025-1036 (2006).
22. Kelly, H. W. & Nelson, H. S. Potential adverse effects of the inhaled corticosteroids. J Allergy Clin Immunol 112, 469-478, 479 (2003).
23. Olsen, P. C. et al. Glucocorticoids decrease Treg cell numbers in lungs of allergic mice. EUR J PHARMACOL 747, 52-58 (2015).
24. Hartl, D. et al. Quantitative and functional impairment of pulmonary CD4+ CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 119, 1258-1266 (2007).
25. Franchimont, D. et al. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J IMMUNOL 164, 1768-1774 (2000).
26. Kingsley, C. I., Karim, M., Bushell, A. R. & Wood, K. J. CD25+ CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10- dependent immunoregulation of alloresponses. J IMMUNOL 168, 1080-1086 (2002).
27. Greer, E. L. & Brunet, A. FOXO transcription factors at the interface between longevity and tumor suppression. ONCOGENE 24, 7410-7425 (2005).
28. Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. CELL 96, 857-868 (1999).
29. Urbich, C. et al. FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J 19, 974-976 (2005).
30. Kops, G. J. et al. Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. MOL CELL BIOL 22, 2025-2036 (2002).
31. Ma, J. et al. Glucocorticoid-induced apoptosis requires FOXO3A activity. Biochem Biophys Res Commun 377, 894-898 (2008).
32. Taniguchi, T. & Minami, Y. The IL-2/IL-2 receptor system: a current overview. CELL 73, 5-8 (1993).
33. Boyman, O., Kovar, M., Rubinstein, M. P., Surh, C. D. & Sprent, J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. SCIENCE 311, 1924-1927 (2006).
34. Yamagiwa, S., Gray, J. D., Hashimoto, S. & Horwitz, D. A. A role for TGF-beta in the generation and expansion of CD4+ CD25+ regulatory T cells from human peripheral blood. J IMMUNOL 166, 7282-7289 (2001).
35. Boyman, O. & Sprent, J. The role of interleukin-2 during homeostasis and activation of the immune system. NAT REV IMMUNOL 12, 180-190 (2012).
36. Doganci, A. et al. IL-2 receptor beta-chain signaling controls immunosuppressive CD4+ T cells in the draining lymph nodes and lung during allergic airway inflammation in vivo. J IMMUNOL 181, 1917-1926 (2008).
37. Yu, A., Zhu, L., Altman, N. H. & Malek, T. R. A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. IMMUNITY 30, 204-217 (2009).
38. Lenardo, M. J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. NATURE 353, 858-861 (1991).
39. Kasaian, M. T. & Miller, D. K. IL-13 as a therapeutic target for respiratory disease. BIOCHEM PHARMACOL 76, 147-155 (2008).
40. Toru, H., Pawankar, R., Ra, C., Yata, J. & Nakahata, T. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells. J Allergy Clin Immunol 102, 491-502 (1998).
41. Stock, P. & Akbari, O. Recent advances in the role of NKT cells in allergic diseases and asthma. Curr Allergy Asthma Rep 8, 165-170 (2008).
42. Hoshino, T., Winkler-Pickett, R. T., Mason, A. T., Ortaldo, J. R. & Young, H. A. IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J IMMUNOL 162, 51-59 (1999).
43. Suzuki, R., Handa, K., Itoh, K. & Kumagai, K. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells. J IMMUNOL 130, 981-987 (1983).
44. Akbari, O. et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. NAT MED 9, 582-588 (2003).
45. Aicher, A. et al. Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. CIRCULATION 107, 604-611 (2003).
46. Robertson, J. M., Jensen, P. E. & Evavold, B. D. DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope. J IMMUNOL 164, 4706-4712 (2000).